Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

NOVOCURE INC.

Filed by NOVOCURE INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 17, 2026
Income
Not reported
Expenses
$110,000.00
Registrant
NOVOCURE INC.
Filing UUID
32733a4a-ef26-4f7d-be63-72bd9419b067
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Literal federal measure citations: H.R.5343, S.1717

TAR · Tariff (miscellaneous tariff bills)

Tariff issues, specifically related to medical device 232.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.